Fact Sheets
2024
2024
The SMID portfolio performed well versus the benchmark on a relative basis in the second quarter, significantly closing the gap in performance exiting Q1 and moving toward providing a level of outperformance we have delivered throughout our long history. The Technology sector was the largest contributor to outperformance, followed by Energy and Consumer Discretionary. We were also pleased to see some of our industrial automation and auto related companies rebound after struggling in recent quarters. Healthcare and Communication sectors were mild negative offsets.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Stocks were mixed in June, with large cap stocks continuing to lead while small cap stocks lagged behind. Inflation data improved during the month, with the Federal Reserve’s favorite inflation indicator, the core Personal Consumption Expenditures Price Index (PCE), posting its lowest year-over-year increase in over three years. Still, the persistent lack of clarity regarding overall economic activity held back any positive sentiment that might have come from better inflation data.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
The Small Cap Value portfolio ended the quarter on a down note, similar to the Russell 2000 and Russell 2000 Value Indices. We lagged the benchmarks for the month due to weaker results in Energy and Communication Services. Our Energy stocks declined after a strong performance in May, and our Communication Services stocks, which focus on the small business market, were negatively impacted by another month of weak small business sentiment.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Exposure to innovative and transformative biotechnology companies has been a part of Pinnacle’s SMID investment strategy since our portfolio’s inception in 1996. Without a doubt, some of our most successful investments have come from this industry. Surprisingly, we have learned over the years that most investment managers avoid biotech stocks due to the inherent binary risks that come with drug development. We wanted to discuss why we think that the opportunity set is constructive.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
Stocks bounced back in May, as more constructive inflation data offered hope that an economic soft landing was still possible. In fact, a soft landing once again became the consensus expectation, with inflation leveling off and the economy showing continued resilience in the face of the Fed’s aggressive rate tightening campaign of the last two years. Corporate profits also came in better than expected, with 1Q earnings on track to grow at a 6% rate year over year, its fastest quarterly pace in two years. Lastly, the geopolitical backdrop quieted down somewhat, offering a welcome (if temporary) respite from the troubling headlines over the past year.
Read MoreRead MoreWatch NowCommentary and Research Papers
2024
2024
After starting the quarter down, small capitalization stocks rebounded in the month of May, but the Russell 2000 and Russell 2000 Value Indices still lag large capitalization companies for the year. Money flow into the largest Artificial Intelligence companies (NVDA, APPL, MSFT and GOOGL) appears to be increasing; those companies made up more than half of the S&P 500 Index’ monthly gain.
Read MoreRead MoreWatch Now
Founded in 1984, Pinnacle Associates, Ltd. is a forward thinking, multi-billion dollar investment advisory firm focused on transparency and putting clients first. We provide advice to individuals and families, institutional investors and other financial institutions.
